The Impact of
Commonly Used Alkylating Agents on Artifactual
Peptide Modification
Version 3 2018-02-09, 23:46
Version 2 2017-10-17, 18:23
Version 1 2017-08-23, 14:11
Posted on 2018-02-09 - 23:46
Iodoacetamide is by far the most
commonly used agent for alkylation
of cysteine during sample preparation for proteomics. An alternative,
2-chloroacetamide, has recently been suggested to reduce the alkylation
of residues other than cysteine, such as the N-terminus, Asp, Glu,
Lys, Ser, Thr, and Tyr. Here we show that although 2-chloroacetamide
reduces the level of off-target alkylation, it exhibits a range of
adverse effects. The most significant of these is methionine oxidation,
which increases to a maximum of 40% of all Met-containing peptides,
compared with 2–5% with iodoacetamide. Increases were also
observed for mono- and dioxidized tryptophan. No additional differences
between the alkylating reagents were observed for a range of other
post-translational modifications and digestion parameters. The deleterious
effects were observed for 2-chloroacetamide from three separate suppliers.
The adverse impact of 2-chloroacetamide on methionine oxidation suggests
that it is not the ideal alkylating reagent for proteomics.
CITE THIS COLLECTION
DataCite
3 Biotech
3D Printing in Medicine
3D Research
3D-Printed Materials and Systems
4OR
AAPG Bulletin
AAPS Open
AAPS PharmSciTech
Abhandlungen aus dem Mathematischen Seminar der Universität Hamburg
ABI Technik (German)
Academic Medicine
Academic Pediatrics
Academic Psychiatry
Academic Questions
Academy of Management Discoveries
Academy of Management Journal
Academy of Management Learning and Education
Academy of Management Perspectives
Academy of Management Proceedings
Academy of Management Review
Hains, Peter G.; Robinson, Phillip J. (2017). The Impact of
Commonly Used Alkylating Agents on Artifactual
Peptide Modification. ACS Publications. Collection. https://doi.org/10.1021/acs.jproteome.7b00022
or
Select your citation style and then place your mouse over the citation text to select it.